Package Leaflet: Information for the User
Aripiprazol Zentiva 5 mg tablets EFG
Aripiprazol Zentiva 10 mg tablets EFG
Aripiprazol Zentiva 15 mg tablets EFG
Aripiprazol Zentiva 30 mg tablets EFG
aripiprazole
Read the entire package leaflet carefully before you start taking this medicine, because it contains important information for you.
Contents of the package leaflet
Aripiprazol Zentiva contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics.
It is used to treat adults and adolescents aged 15 years and older who suffer from a disease characterized by symptoms such as hearing, seeing, and feeling things that do not exist, distrust, false beliefs, incoherent speech, and emotional and behavioral monotony. People in this state may also feel depressed, guilty, restless, or tense.
Aripiprazol Zentiva is used to treat adults and adolescents aged 13 years and older who suffer from a disorder characterized by symptoms such as feeling euphoric, having excessive energy, needing to sleep much less than usual, talking very quickly with flight of ideas, and sometimes severe irritability. In adults, it also prevents this condition in patients who have responded to treatment with Aripiprazol Zentiva.
Do not take Aripiprazol Zentiva
Warnings and precautions
Talk to your doctor before you start taking Aripiprazol Zentiva.
There have been reports of patients experiencing suicidal thoughts and behaviors during treatment with aripiprazole. Tell your doctor immediately if you have thoughts or feelings of harming yourself.
Before you start treatment with Aripiprazol Zentiva, tell your doctor if you suffer from
If you notice that you are gaining weight, developing unusual movements, experiencing somnolence that interferes with your daily activities, having difficulty swallowing, or presenting allergic symptoms, please inform your doctor.
If you suffer from dementia (loss of memory and other mental abilities), you or your caregiver or family member should inform your doctor if you have ever had a stroke or "mini" stroke.
Talk to your doctor immediately if you have thoughts or feelings of harming yourself. There have been reports of patients experiencing suicidal thoughts and behaviors during treatment with aripiprazole.
Talk to your doctor immediately if you notice numbness or stiffness of the muscles with high fever, sweating, altered mental state, or very fast or irregular heartbeat.
Tell your doctor if you, your family, or caregiver notice that you are developing impulses or urges to behave in an unusual way and that you cannot resist the impulse, instinct, or temptation to carry out certain activities that may harm you or others. This is called impulse control disorder and may include behaviors such as gambling addiction, excessive eating or spending, abnormally high sexual appetite, or concern about an increase in sexual thoughts and feelings.
Your doctor may consider adjusting or interrupting the dose.
Aripiprazole may cause somnolence, a drop in blood pressure when standing up, dizziness, and changes in the ability to move and maintain balance, which could lead to falls. You should be cautious, especially if you are an elderly patient or suffer from weakness.
Children and adolescents
Do not use this medicine in children and adolescents under 13 years of age. It is not known if it is safe and effective in these patients.
Other medicines and Aripiprazol Zentiva
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those without a prescription.
Medicines that lower blood pressure: Aripiprazol Zentiva may increase the effect of medicines used to lower blood pressure. Make sure to tell your doctor if you use any medicine to control blood pressure.
If you are taking Aripiprazol Zentiva with another medicine, it may mean that your doctor needs to change your dose of Aripiprazol Zentiva or the other medicine. It is especially important that you mention to your doctor if you are taking:
These medicines may increase the risk of side effects or reduce the effect of Aripiprazol Zentiva; if you notice any unusual symptoms when taking any of these medicines at the same time as Aripiprazol Zentiva, you should tell your doctor.
Medicines that increase serotonin levels are commonly used in diseases that include depression, generalized anxiety disorder, obsessive-compulsive disorder (OCD), and social phobia, as well as migraine and pain:
These medicines may increase the risk of side effects; if you notice any unusual symptoms when taking any of these medicines at the same time as Aripiprazol Zentiva, you should tell your doctor.
Taking Aripiprazol Zentiva with food, drinks, and alcohol
This medicine can be taken independently of meals.
Alcohol consumption should be avoided.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
The following symptoms may occur in newborn babies of mothers who have been treated with Aripiprazol Zentiva in the last trimester of pregnancy (last three months of pregnancy): tremors, stiffness and/or muscle weakness, somnolence, agitation, breathing problems, and difficulty feeding. If your baby develops any of these symptoms, you should contact your doctor.
If you are taking Aripiprazol Zentiva, your doctor will discuss with you whether you should breastfeed your baby, considering the benefit of treatment for you and the benefit of breastfeeding for your baby. If you are being treated with Aripiprazol Zentiva, you should not breastfeed. Talk to your doctor about the best way to feed your baby if you are taking this medicine.
Driving and using machines
During treatment with this medicine, dizziness and vision problems (see section 4) may occur. This should be taken into account when maximum attention is required, for example, when driving or operating machinery.
Aripiprazol Zentiva contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Aripiprazol Zentiva contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, ask your doctor or pharmacist again.
The recommended dose for adults is 15 mg once a day. However, your doctor may prescribe lower or higher doses up to a maximum of 30 mg once a day.
Use in children and adolescents
This medicine should be started with the oral solution (liquid) at a low dose. The dose can be gradually increased to the recommended dose for adolescents of 10 mg once a day. However, your doctor may prescribe lower or higher doses up to a maximum of 30 mg once a day.
If you think the effect of Aripiprazol Zentiva is too strong or too weak, tell your doctor or pharmacist.
Try to take Aripiprazol Zentiva at the same time each day.It does not matter if you take it with or without food. Always take the tablets with water and swallow them whole.
Even if you feel better, do not change or interrupt the daily dose of Aripiprazol Zentiva without consulting your doctor first.
Aripiprazol Zentiva 10 mg, 30 mg tablets: the score line is not intended for breaking the tablet.
If you take more Aripiprazol Zentiva than you should
If you realize that you have taken more Aripiprazol Zentiva than your doctor recommended (or if someone else has taken some of your Aripiprazol Zentiva), contact your doctor immediately. If you cannot contact your doctor, go to the nearest hospital and take the package with you.
Patient who have taken too much aripiprazole have experienced the following symptoms:
Other symptoms may include:
Contact your doctor or the nearest hospital immediately if you experience any of the above symptoms.
If you forget to take Aripiprazol Zentiva
If you forget a dose, take the missed dose as soon as you remember, but do not take a double dose to make up for the missed dose.
If you stop taking Aripiprazol Zentiva
Do not stop your treatment just because you feel better. It is important that you continue taking Aripiprazol Zentiva tablets for the time your doctor has indicated.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Frequent Adverse Effects (may affect up to 1 in 10 patients):
Uncommon Adverse Effects (may affect up to 1 in 100 patients)
The following adverse effects have been reported during the post-marketing phase of oral aripiprazole, but their frequency is unknown (frequency cannot be estimated from available data):
? strong impulse to gamble excessively despite serious personal or family consequences;
? altered or increased sexual interest and disturbing behavior for you or others, for example, increased sexual appetite;
? uncontrolled excessive shopping;
? binge eating (consuming large amounts of food in a short period) or compulsive eating (consuming more food than normal and more than needed to satisfy hunger);
? tendency to wander.
Inform your doctor if you experience any of these behaviors; they will explain how to manage or reduce the symptoms.
In elderly patients with dementia, a higher number of fatal cases have been reported while taking aripiprazole. Additionally, cases of stroke or "mini" stroke have been reported.
Other Adverse Effects in Children and Adolescents
Adolescents aged 13 years or older experienced adverse effects similar in frequency and type to those of adults, except for drowsiness, spasms, or uncontrolled contractions, restlessness, and fatigue, which were very frequent (affecting more than 1 in 10 patients), and upper abdominal pain, dry mouth, increased heart rate, weight gain, increased appetite, muscle fasciculations, involuntary movements of the limbs, and dizziness, especially when standing up after sitting or lying down, which were frequent (affecting more than 1 in 100 patients).
Reporting Adverse Effects
If you experience any adverse effects, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the blister pack and carton after EXP. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Aripiprazol Zentiva
Appearance of Aripiprazol Zentiva and Package Contents
The 5 mg Aripiprazol Zentiva tablets are round, uncoated, white or almost white, beveled edges, smooth, with "5" engraved on one side and flat on the other, with an approximate diameter of 6 mm.
The 10 mg Aripiprazol Zentiva tablets are round, uncoated, white or almost white, with "10" engraved on one side and a score line on the other, with an approximate diameter of 8 mm.
The 15 mg Aripiprazol Zentiva tablets are round, uncoated, white or almost white, beveled edges, smooth, with "15" engraved on one side and flat on the other, with an approximate diameter of 8.8 mm.
The 30 mg Aripiprazol Zentiva tablets are uncoated, capsule-shaped, white or almost white, with "30" engraved on one side and a score line on the other, with approximate dimensions of 15.5 x 8 mm.
Pack sizes: 14, 28, 49, 56, or 98 tablets
Not all pack sizes may be marketed.
Marketing Authorization Holder
Zentiva, k.s.
U kabelovny 130
102 37 Prague 10
Czech Republic
Manufacturer
S.C. Zentiva S.A.
50 Theodor Pallady Blvd.
Bucharest 032266
Romania
You can request more information about this medicine by contacting the local representative of the marketing authorization holder.
België/Belgique/Belgien Zentiva, k.s. Tél/Tel: +32 280 86 420 PV-Belgium@zentiva.com | Lietuva Zentiva, k.s. Tel: +370 52152025 PV-Lithuania@zentiva.com |
Zentiva, k.s. Тел: + 359 244 17 136 PV-Bulgaria@zentiva.com | Luxembourg/Luxemburg Zentiva, k.s. Tél/Tel: +352 208 82330 PV-Luxembourg@zentiva.com |
Ceská republika Zentiva, k.s. Tel: +420 267 241 111 PV-Czech-Republic@zentiva.com | Magyarország Zentiva Pharma Kft Tel.: +36 1 299 1058 PV-Hungary@zentiva.com |
Danmark Zentiva Denmark ApS Tlf: +45 787 68 400 PV-Denmark@zentiva.com | Malta Zentiva, k.s. Tel: +356 2778 0890 PV-Malta@zentiva.com |
Deutschland Zentiva Pharma GmbH Tel: +49 (0) 800 53 53 010 PV-Germany@zentiva.com | Nederland Zentiva, k.s. Tel: +31 202 253 638 PV-Netherlands@zentiva.com |
Eesti Zentiva, k.s. Tel: +372 52 70308 PV-Estonia@zentiva.com | Norge Zentiva Denmark ApS Tlf: +47 219 66 203 PV-Norway@zentiva.com |
Ελλáδα Zentiva, k.s. Τηλ: +30 211 198 7510 PV-Greece@zentiva.com | Österreich Zentiva, k.s. Tel: +43 720 778 877 PV-Austria@zentiva.com |
España Zentiva, k.s. Tel: +34 931 815 250 PV-Spain@zentiva.com | Polska Zentiva Polska Sp. z o.o. Tel: + 48 22 375 92 00 PV-Poland@zentiva.com |
France Zentiva France Tél: +33 (0) 800 089 219 PV-France@zentiva.com | Portugal Zentiva Portugal, Lda Tel: +351210601360 PV-Portugal@zentiva.com |
Hrvatska Zentiva d.o.o. Tel: +385 1 6641 830 PV-Croatia@zentiva.com | România ZENTIVA S.A. Tel: +40 021.304.7597 PV-Romania@zentiva.com |
Ireland Zentiva, k.s. Tel: +353 818 882 243 PV-Ireland@zentiva.com | Slovenija Zentiva, k.s. Tel: +386 360 00 408 PV-Slovenia@zentiva.com |
Ísland Zentiva Denmark ApS Sími: +354 539 0650 PV-Iceland@zentiva.com | Slovenská republika Zentiva, a.s. Tel: +421 2 3918 3010 PV-Slovakia@zentiva.com |
Italia Zentiva Italia S.r.l. Tel: +39-02-38598801 PV-Italy@zentiva.com | Suomi/Finland Zentiva Denmark ApS. Puh/Tel: +358 942 598 648 PV-Finland@zentiva.com |
Κúπρος Zentiva, k.s. Τηλ: +357 240 30 144 PV-Cyprus@zentiva.com | Sverige Zentiva Denmark ApS Tel: +46 840 838 822 PV-Sweden@zentiva.com |
Latvija Zentiva, k.s. Tel: +371 67893939 PV-Latvia@zentiva.com | United Kingdom (Northern Ireland) Zentiva, k.s. Tel: +44 (0) 800 090 2408 PV-United-Kingdom@zentiva.com |
Date of the Last Revision of this Leaflet:
Other Sources of Information
Detailed information about this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu